The DOI matches its Crossref record; 562 of the 562 references it cites were found in a registry or an index.
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Open accessAbstract
Cancer reprogramming is an important facilitator of cancer development and survival, with tumor cells exhibiting a preference for aerobic glycolysis beyond oxidative phosphorylation, even under sufficient oxygen supply condition. This metabolic alteration, known as the Warburg effect, serves as a significant indicator of malignant tumor transformation. The Warburg effect primarily impacts cancer occurrence by influencing the aerobic glycolysis pathway in cancer cells. Key enzymes involved in this process include glucose transporters (GLUTs), HKs, PFKs, LDHs, and PKM2. Moreover, the expression of transcriptional regulatory factors and proteins, such as FOXM1, p53, NF-κB, HIF1α, and c-Myc, can also influence cancer progression. Furthermore, lncRNAs, miRNAs, and circular RNAs play a vital role in directly regulating the Warburg effect. Additionally, gene mutations, tumor microenvironment remodeling, and immune system interactions are closely associated with the Warburg effect. Notably, the development of drugs targeting the Warburg effect has exhibited promising potential in tumor treatment. This comprehensive review presents novel directions and approaches for the early diagnosis and treatment of cancer patients by conducting in-depth research and summarizing the bright prospects of targeting the Warburg effect in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
5 retracted
Items 201–400 of 562
Eichner, L. J., Perry, M.-C., Dufour, C. R., Bertos, N., Park, M., St-Pierre, J., & Giguère, V. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.002 · Cited by 270
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe, H., TAKEHANA, K., Date, M., Shinozaki, T., & Raz, A. (1996) · PubMed · Cited by 269
Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis
Hu, H., Zhu, W., Qin, J., Chen, M., Gong, L., Li, L., Liu, X., Tao, Y., Yin, H., Zhou, H., et al. (2017) · Hepatology · doi:10.1002/hep.28887 · Cited by 269
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
Wang, J., Xie, S., Yang, J., Xiong, H., Jia, Y., Zhou, Y., Chen, Y., Ying, X., Chen, C., Ye, C., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0747-0 · Cited by 264
Intracellular Organization of Insulin Signaling and GLUT4 Translocation
Watson, R. T. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.175 · Cited by 256
Kumar, J. P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8335-4 · Cited by 252
Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells
Zhou, Y., Zhou, Y., Shingu, T., Feng, L., Chen, Z., Ogasawara, M., Keating, M. J., Kondo, S., & Huang, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.260935 · Cited by 250
Guo, W., Qiu, Z., Wang, Z., Wang, Q., Tan, N., Chen, T., Chen, Z., Huang, S., Gu, J., Li, J., et al. (2015) · Hepatology · doi:10.1002/hep.27929 · Cited by 250
Self-citationMetabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
Dasgupta, S., Rajapakshe, K., Zhu, B., Nikolai, B. C., Yi, P., Putluri, N., Choi, J. M., Jung, S. Y., Coarfa, C., Westbrook, T. F., et al. (2018) · Nature · doi:10.1038/s41586-018-0018-1 · Cited by 250
Cytochalasin B: Inhibition of Glucose and Glucosamine Transport
Estensen, R. D., & Plagemann, P. G. W. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1430 · Cited by 249
Cui, J., Shi, M., Xie, D., Wei, D., Jia, Z., Zheng, S., Gao, Y., Huang, S., & Xie, K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2407 · Cited by 246
Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
Stambolsky, P., Tabach, Y., Fontemaggi, G., Weisz, L., Maor-Aloni, R., Sigfried, Z., Shiff, I., Kogan, I., Shay, M., Kalo, E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.025 · Cited by 245
p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2
Contractor, T., & Harris, C. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1215 · Cited by 245
Cheong, J.-H., Park, E. S., Liang, J., Dennison, J. B., Tsavachidou, D., Nguyen-Charles, C., Wa Cheng, K., Hall, H., Zhang, D., Lu, Y., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0497 · Cited by 245
Wang, B., Hsu, S.-H., Frankel, W., Ghoshal, K., & Jacob, S. T. (2012) · Hepatology · doi:10.1002/hep.25632 · Cited by 241
Kaji, K., Nishimura, N., Seki, K., Sato, S., Saikawa, S., Nakanishi, K., Furukawa, M., Kawaratani, H., Kitade, M., Moriya, K., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31193 · Cited by 241
Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics
Garcia, S. N., Guedes, R. C., & Marques, M. M. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666181213092652 · Cited by 227
K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif
Tsai, F. D., Lopes, M. S., Zhou, M., Court, H., Ponce, O., Fiordalisi, J. J., Gierut, J. J., Cox, A. D., Haigis, K. M., & Philips, M. R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412811112 · Cited by 226
Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming
Jin, J., Qiu, S., Wang, P., Liang, X., Huang, F., Wu, H., Zhang, B., Zhang, W., Tian, X., Xu, R., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1351-4 · Cited by 225
Metabolic Dependencies in RAS-Driven Cancers
Kimmelman, A. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2425 · Cited by 224
Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells
Smolková, K., Plecitá-Hlavatá, L., Bellance, N., Benard, G., Rossignol, R., & Ježek, P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.003 · Cited by 223
mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells
Pusapati, R. V., Daemen, A., Wilson, C., Sandoval, W., Gao, M., Haley, B., Baudy, A. R., Hatzivassiliou, G., Evangelista, M., & Settleman, J. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.018 · Cited by 222
Liu, H., Liu, Y., & Zhang, J.-T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0445 · Cited by 216
Self-citationSystemic treatment of soft-tissue sarcoma—gold standard and novel therapies
Linch, M., Miah, A. B., Thway, K., Judson, I. R., & Benson, C. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.26 · Cited by 216
Kapoor, K., Finer-Moore, J. S., Pedersen, B. P., Caboni, L., Waight, A., Hillig, R. C., Bringmann, P., Heisler, I., Müller, T., Siebeneicher, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603735113 · Cited by 213
CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc
Shen, S., Yao, T., Xu, Y., Zhang, D., Fan, S., & Ma, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01269-4 · Cited by 212
CDK8: A positive regulator of transcription
Galbraith, M. D., Donner, A. J., & Espinosa, J. M. (2010) · Transcription · doi:10.4161/trns.1.1.12373 · Cited by 211
Lactate dehydrogenase A silencing in IDH mutant gliomas
Chesnelong, C., Chaumeil, M. M., Blough, M. D., Al-Najjar, M., Stechishin, O. D., Chan, J. A., Pieper, R. O., Ronen, S. M., Weiss, S., Luchman, H. A., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not243 · Cited by 210
The Role of Mitochondria in the Regulation of Hypoxia-inducible Factor 1 Expression during Hypoxia
Agani, F. H., Pichiule, P., Chavez, J. C., & LaManna, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005643200 · Cited by 210
Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
Goldin, N., Arzoine, L., Heyfets, A., Israelson, A., Zaslavsky, Z., Bravman, T., Bronner, V, Notcovich, A., Shoshan-Barmatz, V, & Flescher, E. (2008) · Oncogene · doi:10.1038/onc.2008.108 · Cited by 208
Logozzi, M., Mizzoni, D., Angelini, D., Di Raimo, R., Falchi, M., Battistini, L., & Fais, S. (2018) · Cancers · doi:10.3390/cancers10100370 · Cited by 208
Wang, L., Brooks, A. N., Fan, J., Wan, Y., Gambe, R., Li, S., Hergert, S., Yin, S., Freeman, S. S., Levin, J. Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.005 · Cited by 207
Li, L., Kang, L., Zhao, W., Feng, Y., Liu, W., Wang, T., Mai, H., Huang, J., Chen, S., Liang, Y., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.034 · Cited by 207
Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2
Wang, C., Li, Y., Yan, S., Wang, H., Shao, X., Xiao, M., Yang, B., Qin, G., Kong, R., Chen, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16966-3 · Cited by 205
KRAS4A directly regulates hexokinase 1
Amendola, C. R., Mahaffey, J. P., Parker, S. J., Ahearn, I. M., Chen, W.-C., Zhou, M., Court, H., Shi, J., Mendoza, S. L., Morten, M. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1832-9 · Cited by 203
Jitschin, R., Hofmann, A. D., Bruns, H., Gießl, A., Bricks, J., Berger, J., Saul, D., Eckart, M. J., Mackensen, A., & Mougiakakos, D. (2014) · Blood · doi:10.1182/blood-2013-10-532200 · Cited by 201
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models
Nguyen, T. T. T., Zhang, Y., Shang, E., Shu, C., Torrini, C., Zhao, J., Bianchetti, E., Mela, A., Humala, N., Mahajan, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129049 · Cited by 201
Liberti, M. V., Dai, Z., Wardell, S. E., Baccile, J. A., Liu, X., Gao, X., Baldi, R., Mehrmohamadi, M., Johnson, M. O., Madhukar, N. S., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.017 · Cited by 199
Burant, C. F., & Bell, G. I. (1992) · Biochemistry · doi:10.1021/bi00157a032 · Cited by 197
Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
Pisarsky, L., Bill, R., Fagiani, E., Dimeloe, S., Goosen, R. W., Hagmann, J., Hess, C., & Christofori, G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.028 · Cited by 197
Wang, S., Zhang, Y., Cai, Q., Ma, M., Jin, L. Y., Weng, M., Zhou, D., Tang, Z., Wang, J. D., & Quan, Z. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1078-z · Cited by 196
Wnt/Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism
Lee, S. Y., Jeon, H. M., Ju, M. K., Kim, C. H., Yoon, G., Han, S. I., Park, H. G., & Kang, H. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0006 · Cited by 195
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Wood, T. E., Dalili, S., Simpson, C. D., Hurren, R., Mao, X., Saiz, F. S., Gronda, M., Eberhard, Y., Minden, M. D., Bilan, P. J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0569 · Cited by 195
PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis
Liang, J., Cao, R., Zhang, Y., Xia, Y., Zheng, Y., Li, X., Wang, L., Yang, W., & Lu, Z. (2016) · Nature Communications · doi:10.1038/ncomms12431 · Cited by 194
The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer
Li, W., Zhang, Z., Liu, X., Cheng, X., Zhang, Y., Han, X., Zhang, Y., Liu, S., Yang, J., Xu, B., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94233 · Cited by 194
McBrayer, S. K., Cheng, J. C., Singhal, S., Krett, N. L., Rosen, S. T., & Shanmugam, M. (2012) · Blood · doi:10.1182/blood-2011-09-377846 · Cited by 192
Yang, Z., Zhao, N., Cui, J., Wu, H., Xiong, J., & Peng, T. (2020) · Cellular Oncology · doi:10.1007/s13402-019-00476-6 · Cited by 192
Gu, J.-W., Makey, K. L., Tucker, K. B., Chinchar, E., Mao, X., Pei, I., Thomas, E. Y., & Miele, L. (2013) · Vascular Cell · doi:10.1186/2045-824x-5-9 · Cited by 189
VDAC1: from structure to cancer therapy
Shoshan-Barmatz, V., & Mizrachi, D. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00164 · Cited by 189
Fong, S. S., Nanchen, A., Palsson, B. O., & Sauer, U. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510016200 · Cited by 188
Malakar, P., Stein, I., Saragovi, A., Winkler, R., Stern-Ginossar, N., Berger, M., Pikarsky, E., & Karni, R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-1432 · Cited by 188
Hou, Y., Zhang, Q., Pang, W., Hou, L., Liang, Y., Han, X., Luo, X., Wang, P., Zhang, X., Li, L., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00804-0 · Cited by 183
Fu, B., Xue, J., Li, Z., Shi, X., Jiang, B.-H., & Fang, J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0526 · Cited by 181
Su, M.-A., Huang, Y.-T., Chen, I.-T., Lee, D.-Y., Hsieh, Y.-C., Li, C.-Y., Ng, T. H., Liang, S.-Y., Lin, S.-Y., Huang, S.-W., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004196 · Cited by 181
Wang, Z., Qiu, H., He, J., Liu, L., Xue, W., Fox, A., Tickner, J., & Xu, J. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29186 · Cited by 181
Self-citationHexokinase II mRNA and gene structure, regulation by insulin, and evolution.
Printz, R. L., Koch, S., Potter, L. R., O'Doherty, R. M., Tiesinga, J. J., Moritz, S., & Granner, D. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53521-3 · Cited by 179
Lin28/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1
Ma, X., Li, C., Sun, L., Huang, D., Li, T., He, X., Wu, G., Yang, Z., Zhong, X., Song, L., et al. (2014) · Nature Communications · doi:10.1038/ncomms6212 · Cited by 179
Epidermal Sensing of Oxygen Is Essential for Systemic Hypoxic Response
Boutin, A. T., Weidemann, A., Fu, Z., Mesropian, L., Gradin, K., Jamora, C., Wiesener, M., Eckardt, K.-U., Koch, C. J., Ellies, L. G., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.038 · Cited by 177
Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c–SIRT2 axis
Cha, Y., Han, M.-J., Cha, H.-J., Zoldan, J., Burkart, A., Jung, J. H., Jang, Y., Kim, C.-H., Jeong, H.-C., Kim, B.-G., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3517 · Cited by 176
SF3B1 mutations constitute a novel therapeutic target in breast cancer
Maguire, S. L., Leonidou, A., Wai, P., Marchiò, C., Ng, C. K., Sapino, A., Salomon, A., Reis‐Filho, J. S., Weigelt, B., & Natrajan, R. C. (2015) · The Journal of Pathology · doi:10.1002/path.4483 · Cited by 175
Jin, L., Wessely, O., Marcusson, E. G., Ivan, C., Calin, G. A., & Alahari, S. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2162 · Cited by 175
HAb18G (CD147), a cancer‐associated biomarker and its role in cancer detection
Li, Y., Xu, J., Chen, L., Zhong, W., Zhang, Z., Mi, L., Zhang, Y., Liao, C., Bian, H., Jiang, J., et al. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03280.x · Cited by 174
Martinez-Outschoorn, U. E., Goldberg, A. F., Lin, Z., Ko, Y.-H., Flomenberg, N., Wang, C., Pavlides, S., Pestell, R. G., Howell, A., Sotgia, F., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.10.17780 · Cited by 174
Liao, M., Liao, W., Xu, N., Li, B., Liu, F., Zhang, S., Wang, Y., Wang, S., Zhu, Y., Chen, D., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.035 · Cited by 174
Self-citationGlucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase.
Rempel, A., Mathupala, S. P., Griffin, C. A., Hawkins, A. L., & Pedersen, P. L. (1996) · PubMed · Cited by 173
The Two Sides of YY1 in Cancer: A Friend and a Foe
Sarvagalla, S., Kolapalli, S. P., & Vallabhapurapu, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01230 · Cited by 173
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival
Pathria, G., Scott, D. A., Feng, Y., Lee, J. S., Fujita, Y., Zhang, G., Sahu, A. D., Ruppin, E., Herlyn, M., Osterman, A. L., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201899735 · Cited by 171
Shangguan, X., He, J., Ma, Z., zhang, W., Ji, Y., Shen, K., Yue, Z., Li, W., Xin, Z., Zheng, Q., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22163-7 · Cited by 171
The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand
Epstein, T., Gatenby, R. A., & Brown, J. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185085 · Cited by 170
Zhang, H.-N., Yang, L., Ling, J.-Y., Czajkowsky, D. M., Wang, J.-F., Zhang, X.-W., Zhou, Y.-M., Ge, F., Yang, M.-K., Xiong, Q., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521316112 · Cited by 168
Self-citationPKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis
Wang, Y., Hao, F., Nan, Y., Qu, L., Na, W., Jia, C., & Chen, X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27854 · Cited by 168
Feng, Y., Yang, Y., Zhao, X., Fan, Y., Zhou, L., Rong, J., & Yu, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2028-9 · Cited by 168
Zhang, T., Zhu, X., Wu, H., Jiang, K., Zhao, G., Shaukat, A., Deng, G., & Qiu, C. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14276 · Cited by 165
Intracellular pH controls WNT downstream of glycolysis in amniote embryos
Oginuma, M., Harima, Y., Tarazona, O. A., Diaz-Cuadros, M., Michaut, A., Ishitani, T., Xiong, F., & Pourquié, O. (2020) · Nature · doi:10.1038/s41586-020-2428-0 · Cited by 165
Lactic acid in macrophage polarization: The significant role in inflammation and cancer
Zhou, H.-C., Yan, X.-Y., Yu, W.-W., Liang, X.-Q., Du, X.-Y., Liu, Z.-C., Long, J.-P., Zhao, G.-H., & Liu, H.-B. (2022) · International Reviews of Immunology · doi:10.1080/08830185.2021.1955876 · Cited by 165
Multiple molecular forms of ATP: Hexose 6-phosphotransferase from rat liver
González, C., Ureta, T., Sánchez, R., & Niemeyer, H. (1964) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(64)90038-5 · Cited by 163
Taniguchi, K., Sugito, N., Kumazaki, M., Shinohara, H., Yamada, N., Nakagawa, Y., Ito, Y., Otsuki, Y., Uno, B., Uchiyama, K., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.026 · Cited by 163
An, J., Lv, W., & Zhang, Y. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s147586 · Cited by 163
The immunologic Warburg effect: Evidence and therapeutic opportunities in autoimmunity
Kornberg, M. D. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1486 · Cited by 163
Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations
Webb, B. A., Forouhar, F., Szu, F.-E., Seetharaman, J., Tong, L., & Barber, D. L. (2015) · Nature · doi:10.1038/nature14405 · Cited by 162
Shen, Y., Xu, J., Pan, X., Zhang, Y., Weng, Y., Zhou, D., & He, S. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2485-1 · Cited by 162
Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1
Zhang, Y., Huang, W., Yuan, Y., Li, J., Wu, J., Yu, J., He, Y., Wei, Z., & Zhang, C. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01619-6 · Cited by 161
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
Brugarolas, J., & Kaelin, W. G. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.020 · Cited by 160
Melstrom, L. G., Salabat, M. R., Ding, X.-Z., Milam, B. M., Strouch, M. J., Pelling, J. C., & Bentrem, D. J. (2008) · Pancreas · doi:10.1097/mpa.0b013e3181735ccb · Cited by 159
METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism
Han, L., Dong, L., Leung, K., Zhao, Z., Li, Y., Gao, L., Chen, Z., Xue, J., Qing, Y., Li, W., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2022.12.006 · Cited by 159
Huang, Q., Li, J., Xing, J., Li, W., Li, H., Ke, X., Zhang, J., Ren, T., Shang, Y., Yang, H., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.035 · Cited by 158
Self-citationLee, G., Won, H.-S., Lee, Y.-M., Choi, J.-W., Oh, T.-I., Jang, J.-H., Choi, D.-K., Lim, B.-O., Kim, Y. J., Park, J.-W., et al. (2016) · Scientific Reports · doi:10.1038/srep18928 · Cited by 158
Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth
Reckzeh, E. S., Karageorgis, G., Schwalfenberg, M., Ceballos, J., Nowacki, J., Stroet, M. C. M., Binici, A., Knauer, L., Brand, S., Choidas, A., et al. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.06.005 · Cited by 158
Liao, M., Qin, R., Huang, W., Zhu, H.-P., Peng, F., Han, B., & Liu, B. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01260-0 · Cited by 158
Self-citationMondal, S., Roy, D., Bhattacharya, S. S., Jin, L., Jung, D., Zhang, S., Kalogera, E., Staub, J. K., Wang, Y., Xuyang, W., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31868 · Cited by 156
Goel, A., Mathupala, S. P., & Pedersen, P. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300608200 · Cited by 155
The Warburg effect and glucose-derived cancer theranostics
Tekade, R. K., & Sun, X. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.003 · Cited by 155
MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN
Yang, T., Yang, X., Wang, X., Wang, Y., Zhou, B., & Song, Z. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-68 · Cited by 154
Zhu, Z., Jiang, W., McGinley, J. N., & Thompson, H. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0453 · Cited by 153
Chu, Z., Huo, N., Zhu, X., Liu, H., Cong, R., Ma, L., Kang, X., Xue, C., Li, J., Li, Q., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.036 · Cited by 153
Wei, L., Zhou, Y., Dai, Q., Qiao, C., Zhao, L., Hui, H., Lu, N., & Guo, Q.-L. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.131 · Cited by 147
MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer
Vriens, M. R., Weng, J., Suh, I., Huynh, N., Guerrero, M. A., Shen, W. T., Duh, Q., Clark, O. H., & Kebebew, E. (2011) · Cancer · doi:10.1002/cncr.26587 · Cited by 142
Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment
Justus, C., Sanderlin, E. J., & Yang, L. V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511055 · Cited by 142
The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation
Yan, M., Gingras, M., Dunlop, E. A., Nouët, Y., Dupuy, F., Jalali, Z., Possik, E., Coull, B. J., Kharitidi, D., Dydensborg, A. B., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71749 · Cited by 141
An elegant miRror: microRNAs in stem cells, developmental timing and cancer
Nimmo, R. A., & Slack, F. J. (2009) · Chromosoma · doi:10.1007/s00412-009-0210-z · Cited by 140
Singh, R. P., Dhanalakshmi, S., Agarwal, C., & Agarwal, R. (2004) · Oncogene · doi:10.1038/sj.onc.1208276 · Cited by 139
Ren, F., Wu, H., Lei, Y., Zhang, H., Liu, R., Zhao, Y., Chen, X., Zeng, D., Tong, A., Chen, L., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-81 · Cited by 139
Lu, C., Qin, L., Liu, H.-C., Candas, D., Fan, M., & Li, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121046 · Cited by 138
Molecular mechanisms of GLUT4 regulation in adipocytes
Govers, R. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.01.005 · Cited by 138
Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
Shen, H. M., Hau, E. K. C., Joshi, S. M., Dilda, P. J., & McDonald, K. L. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0247 · Cited by 138
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
Gustafsson, N., Färnegårdh, K., Bonagas, N., Ninou, A. H., Groth, P., Wiita, E., Jönsson, M., Hallberg, K., Lehto, J., Pennisi, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06287-x · Cited by 138
Calorie restriction and cancer prevention: a mechanistic perspective
Hursting, S. D., Dunlap, S. M., Ford, N. A., Hursting, M. J., & Lashinger, L. M. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-10 · Cited by 137
Emerging landscape of circular RNAs in lung cancer
Hu, W., Bi, Z., Chen, Z., Liu, C., Li, L., Zhang, F., Zhou, Q. Y., Zhu, W., Song, Y., Zhan, B.-T., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.006 · Cited by 137
Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine
Li, Q., Manolescu, A. R., Ritzel, M. W. L., Yao, S. Y. M., Slugoski, M. D., Young, J. D., Chen, X., & Cheeseman, C. I. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00396.2003 · Cited by 136
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
Codrici, E., Enciu, A., Popescu, I. D., Mihai, S., & Tănase, C. (2016) · Stem Cells International · doi:10.1155/2016/5728438 · Cited by 135
Xu, Q., Shao, M., Sun, H.-J., Shen, Y. L., Meng, D., & Huo, W. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.002 · Cited by 134
Wu, H., Pan, L., Gao, C., Xu, H., Li, Y., Zhang, L., Ma, L., Li, M., Sun, X., & Qin, H. (2019) · Molecules · doi:10.3390/molecules24101993 · Cited by 134
Cheng, A., Zhang, P., Wang, B., Yang, D., Duan, X., Jiang, Y., Tian, X., Jiang, Y. P., Shi, J., Ding, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13485-8 · Cited by 134
Liu, J., Pan, C., Guo, L., Wu, M., Guo, J., Peng, S., Wu, Q., & Zuo, Q. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0302-1 · Cited by 133
Lu, Z., Li, Y., Wang, J., Che, Y., Sun, S., Huang, J., Chen, Z., & He, J. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0518-0 · Cited by 132
Narducci, M. G., Arcelli, D., Picchio, M. C., Lazzeri, C., Pagani, E., Sampogna, F., Scala, E., Fadda, P., Cristofoletti, C., Facchiano, A., et al. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.32 · Cited by 131
Song, R., Song, H., Liang, Y., Yin, D., Zhang, H., Zheng, T., Wang, J., Lu, Z., Song, X., Pei, T., et al. (2014) · Hepatology · doi:10.1002/hep.27312 · Cited by 131
Chen, X., Li, L.-Y., Guan, Y.-D., Yang, J., & Cheng, Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.47 · Cited by 131
Mediator kinase module and human tumorigenesis
Clark, A. D., Oldenbroek, M., & Boyer, T. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1064854 · Cited by 130
Yan, J. C., Zhang, Y., She, Q., Li, X., Peng, L., Wang, X., Liu, S., Shen, X., Zhang, W., Dong, Y., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480028 · Cited by 130
Wong, T. L., Ng, K. Y., Tan, K. V., Chan, L.-H., Zhou, L., Che, N., Hoo, R. L. C., Lee, T. K., Richard, S., Lo, C. M., et al. (2019) · Hepatology · doi:10.1002/hep.30923 · Cited by 130
LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect
Xiang, S., Gu, H., Jin, L., Thorne, R. F., Zhang, X. D., & Wu, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711257115 · Cited by 129
Dai, W., Wang, F., Lu, J., Xia, Y., He, L., Chen, K., Li, J., Li, S., Liu, T., Zheng, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3800 · Cited by 128
Dando, I., Donadelli, M., Costanzo, C., Dalla Pozza, E., D'Alessandro, A., Zolla, L., & Palmieri, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.151 · Cited by 128
Liao, M., Zhang, J. C., Wang, G., Wang, L., Liu, J., Ouyang, L., & Liu, B. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01180 · Cited by 128
Self-citationStructural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)
Li, H., & Jogl, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807821200 · Cited by 127
Ke, X., Fei, F., Chen, Y., Xu, L., Zhang, Z., Huang, Q., Zhang, H., Yang, H., Chen, Z., & Xing, J. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs196 · Cited by 126
Jung, K., Lee, J. H., Quach, C. H. T., Paik, J.-Y., Oh, H., Park, J. W., Lee, E. J., Moon, S. H., & Lee, K.-H. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.115436 · Cited by 125
Du, Y., Wei, N., Ma, R., Jiang, S., & Song, D. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02952-6 · Cited by 125
3‐Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
Ihrlund, L. S., Hernlund, E., Khan, O. M., & Shoshan, M. C. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.01.003 · Cited by 124
Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells
Bhatt, A. N., Chauhan, A., Khanna, S., Rai, Y., Singh, S. P., Soni, R., Kalra, N., & Dwarakanath, B. S. R. (2015) · BMC Cancer · doi:10.1186/s12885-015-1368-9 · Cited by 124
Straus, D. S. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-78 · Cited by 124
Karageorgis, G., Reckzeh, E. S., Ceballos, J., Schwalfenberg, M., Sievers, S., Ostermann, C., Pahl, A., Ziegler, S., & Waldmann, H. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0132-6 · Cited by 124
Chen, X., Yu, J., Tian, H., Shan, Z., Liu, W., Pan, Z., & Ren, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28692 · Cited by 122
Huang, C.-Y., Kuo, W.-T., Huang, Y.-C., Lee, T., & Yu, L. C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.149 · Cited by 119
Dong, H., Wang, W. J., Mo, S., Liu, Q., Chen, X., Chen, R., Zhang, Y., Zou, K., Ye, M., He, X., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13758 · Cited by 119
Ning, X., Qi, H., Li, R., Li, Y., Jin, Y., McNutt, M. A., Liu, J., & Yin, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.064 · Cited by 118
Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-κB/c-Myc pathway
Jiao, L., Wang, S., Zheng, Y., Wang, N., Yang, B., Wang, D., Yang, D., Mei, W., Zhao, Z., & Wang, Z. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.01.016 · Cited by 118
Self-citationMutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
Liu, Z., Yoshimi, A., Wang, J., Cho, H., Chun-Wei Lee, S., Ki, M., Bitner, L., Chu, T., Shah, H., Liu, B., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1330 · Cited by 118
Self-citationMicroRNA-26a regulates glucose metabolism by direct targeting PDHX in colorectal cancer cells
Chen, B., Liu, Y., Jin, X., Lu, W., Liu, J., Xia, Z., Yuan, Q., Zhao, X., Xu, N., & Liang, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-443 · Cited by 117
Why do tumor cells have a high aerobic glycolysis?
Racker, E. (1976) · Journal of Cellular Physiology · doi:10.1002/jcp.1040890429 · Cited by 117
Phosphofructokinase: A mediator of glycolytic flux in cancer progression
Hasawi, N. A., Alkandari, M. F., & Luqmani, Y. A. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.05.007 · Cited by 116
Organ-Specific Cancer Metabolism and Its Potential for Therapy.
Elia, I., Schmieder, R., Christen, S., & Fendt, S. (2016) · Handbook of Experimental Pharmacology · doi:10.1007/164_2015_10 · Cited by 115
The role of GLUT2 in dietary sugar handling
Leturque, A., Brot‐Laroche, E., Gall, M. L., Stolarczyk, É., & Tobin, V. (2005) · Journal of Physiology and Biochemistry · doi:10.1007/bf03168378 · Cited by 115
Wei, J., Wu, J., Xu, W., Nie, H., Zhou, R., Wang, R., Liu, Y., Tang, G., & Wu, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0623-9 · Cited by 114
Chen, Z., Zuo, X., Zhang, Y., Han, G., Zhang, L., Wu, J., & Wang, X. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0616-8 · Cited by 113
Six1: A critical transcription factor in tumorigenesis
Wu, W., Ren, Z., Li, P., Yu, D., Chen, J., Huang, R., & Liu, H. (2014) · International Journal of Cancer · doi:10.1002/ijc.28755 · Cited by 112
L-Lactate Dehydrogenase A4- and A3B Isoforms Are Bona Fide Peroxisomal Enzymes in Rat Liver
Baumgart‐Vogt, E., Fahimi, H. D., Stich, A., & Völkl, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3846 · Cited by 112
Wang, Y., Rathinam, R., Walch, A., & Alahari, S. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012617 · Cited by 111
Gao, T., Liu, X., He, B., Nie, Z., Zhu, C., Zhang, P., & Wang, S. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0506-2 · Cited by 111
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
Dabral, S., Muecke, C., Valasarajan, C., Schmoranzer, M., Wietelmann, A., Semenza, G. L., Meister, M. A., Muley, T., Seeger‐Nukpezah, T., Samakovlis, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10044-z · Cited by 111
Nie, H., Li, J., Yang, X., Qing-zhen, C., Feng, M., Xue, F., Wei, L., Qin, W., Gu, J., Xia, Q., et al. (2015) · Hepatology · doi:10.1002/hep.27940 · Cited by 110
Wang, H., Zhao, L., Zhu, L., Wang, Y., Pan, D., Yao, J., You, Q., & Guo, Q. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22052 · Cited by 109
Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins
Zhan, T., Digel, M., Kuech, E., Stremmel, W., & Füllekrug, J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22984 · Cited by 109
Firestein, R., Shima, K., Nosho, K., Irahara, N., Baba, Y., Bojarski, E. F., Giovannucci, E. L., Hahn, W. C., Fuchs, C. S., & Ogino, S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24908 · Cited by 109
Liu, H., Lyu, H., Jiang, G., Chen, D., Ruan, S., Liu, S., Zhou, L., Yang, M., Zeng, S., He, Z., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0800 · Cited by 109
Self-citationPhosphoglycerate kinase 1 as a promoter of metastasis in colon cancer
Ahmad, S. S., Glatzle, J., Bajaeifer, K., Bühler, S., Lehmann, T. G., Königsrainer, I., Vollmer, J.-P., Sipos, B., AHMAD, S. S., Northoff, H., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1971 · Cited by 108
The role of cancer stem cells in the modulation of anti-tumor immune responses
Maccalli, C., Rasul, K. I., Elawad, M., & Ferrone, S. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.09.006 · Cited by 107
Aylon, Y., & Oren, M. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.002 · Cited by 106
Puig, T., Aguilar, H., Cufí, S., Oliveras, G., Turrado, C., Ortega‐Gutiérrez, S., Benhamú, B., López-Rodríguez, M. L., Urruticoechea, A., & Colomer, R. (2011) · Breast Cancer Research · doi:10.1186/bcr3077 · Cited by 106
Li, H., Song, J., He, Y., Liu, Y., Liu, Z., Sun, W., Hu, W., Lei, Q., Hu, X., Chen, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202105126 · Cited by 106
Stem cell signature in glioblastoma: therapeutic development for a moving target
Nakano, I. (2014) · Journal of neurosurgery · doi:10.3171/2014.9.jns132253 · Cited by 105
Yu, W., Lin, R., He, X., Yang, X., Zhang, H., Hu, C., Liu, R., Huang, Y., Qin, Y., & Gao, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.04.006 · Cited by 105
Yuan, M., Tu, B., Li, H., Pang, H., Zhang, N., Fan, M., Bai, J., Wang, W., Shu, Z., DuFort, C. C., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00426-6 · Cited by 105
CDK8 Kinase Activity Promotes Glycolysis
Galbraith, M. D., Andrysík, Z., Pandey, A., Hoh, M., Bonner, E. A., Hill, A. A., Sullivan, K. D., & Espinosa, J. M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.058 · Cited by 103
Molecular Crosstalk Between MYC and HIF in Cancer
Li, Y., Sun, X., Qian, D. Z., & Dai, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590576 · Cited by 102
Zhang, L., Lou, J., Lü, M., Gao, C., Zhao, S., Li, B., Liang, S., Li, Y., Li, D., & Liu, M. (2015) · The EMBO Journal · doi:10.15252/embj.201591803 · Cited by 101
Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3
Ceballos, J., Schwalfenberg, M., Karageorgis, G., Reckzeh, E. S., Sievers, S., Ostermann, C., Pahl, A., Sellstedt, M., Nowacki, J., Corrales, M. A. C., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201909518 · Cited by 101
Pantuck, A. J., An, J., Liu, H., & Rettig, M. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2211 · Cited by 100
Melstrom, L. G., Salabat, M. R., Ding, X.-Z., Strouch, M. J., Grippo, P. J., Mirzoeva, S., Pelling, J. C., & Bentrem, D. J. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2010.10.041 · Cited by 98
The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression
Ma, B., Cheng, H., Mu, C., Geng, G., Zhao, T., Luo, Q., Ma, K., Chang, R., Liu, Q., Gao, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08618-y · Cited by 98
Liu, G., Ye, Z., Zhao, X., & Ji, Z. (2017) · PubMed · Cited by 98
Zheng, X., Zhou, Y., Chen, W., Chen, L., Lu, J., He, F., Xu, L., & Zhao, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495552 · Cited by 97
Coletta, R. D., Christensen, K. L., Micalizzi, D. S., Jedlicka, P., Varella‐Garcia, M., & Ford, H. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3141 · Cited by 96
Shimizu, K., & Matsuoka, Y. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.12.007 · Cited by 96
Lecerf, C., Bourhis, X. L., & Adriaenssens, É. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03240-z · Cited by 96
Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis
Huangyang, P., Li, F., Lee, P., Nissim, I., Weljie, A. M., Mancuso, A., Li, B., Keith, B., Yoon, S. S., & Simon, M. C. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.012 · Cited by 96
MicroRNA-mediated regulatory circuits: outlook and perspectives
Corà, D., Re, A., Caselle, M., & Bussolino, F. (2017) · Physical Biology · doi:10.1088/1478-3975/aa6f21 · Cited by 95
Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy
Gordin, D., Shah, H., Shinjo, T., St-Louis, R., Qi, W., Park, K., Paniagua, S. M., POBER, D. M., Wu, I., Bahnam, V., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2585 · Cited by 95
Tilekar, K. N., Upadhyay, N., Iancu, C. V., Pokrovsky, V. S., Choe, J., & Ramaa, C. S. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188457 · Cited by 95
RhoBTB3: A Rho GTPase-Family ATPase Required for Endosome to Golgi Transport
Espinosa, E. J., Calero, M., Sridevi, K., & Pfeffer, S. R. (2009) · Cell · doi:10.1016/j.cell.2009.03.043 · Cited by 94
Lu, Q., Zhang, L., Yee, J. K., Go, V. W., & Lee, W. P. (2014) · Metabolomics · doi:10.1007/s11306-014-0672-8 · Cited by 93
Wang, K., Fan, H., Chen, Q., Ma, G., Ming, Z., Zhang, X., Zhang, Y., & Yu, J. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000132 · Cited by 93
Li, L., Li, L., Li, W., Chen, T., Zou, B., Zhao, L., Wang, H., Wang, X., Xu, L., Liu, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07127-8 · Cited by 93
Chen, X., Gu, P., Xie, R., Han, J., Liu, H., Wang, B., Xie, W., Xie, W., Zhong, G., Chen, C., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12999 · Cited by 92
Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3
Boyd, S., Brookfield, J. L., Critchlow, S. E., Cumming, I. A., Curtis, N. J., Debreczeni, J. E., Degorce, S. L., Donald, C. S., Evans, N. J., Groombridge, S. D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00352 · Cited by 91
Metabolic Imaging of Glutamine in Cancer
Zhu, L., Plöessl, K., Zhou, R., Mankoff, D. A., & Kung, H. F. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.182345 · Cited by 91
Stromal cell–mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling
Jitschin, R., Braun, M., Qorraj, M., Saul, D., Blanc, K. L., Zenz, T., & Mougiakakos, D. (2015) · Blood · doi:10.1182/blood-2014-10-607036 · Cited by 90
Zhang, R., Su, J., Xue, S., Yang, H., Ju, L., Ji, Y., Wu, K.-H., Zhang, Y., Zhang, Y.-X., Hu, J., et al. (2016) · PubMed Central · Cited by 90
Wang, Z., Cai, H., Cai, H., Lin, L., Tang, M., Cai, H., & Cai, H. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24763 · Cited by 88
Self-citationZhou, Y., Zheng, X., Lu, J., Chen, W., Xu, L., & Zhao, L. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488273 · Cited by 88
Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment
Zhou, Y., Huang, Z., Su, J., Li, J., Zhao, S., Wu, L., Jiangling, Z., He, Y., Zhang, G., Tao, J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32756 · Cited by 88
Self-citationSun, Q., Li, S., Wang, Y., Peng, H., Zhang, X., Zheng, Y., Li, C., Li, L., Chen, R., Chen, X., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-017-0034-y · Cited by 87
Pu, Z., Xu, M., Yuan, X., Xie, H., & Zhao, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.08.023 · Cited by 87
Kesarwani, A. K., Ramirez, O., Gupta, A. K., Yang, X., Murthy, T., Minella, A. C., & Pillai, M. M. (2016) · Oncogene · doi:10.1038/onc.2016.279 · Cited by 86
Fu, D., He, C., Wei, J., Zhang, Z., Luo, Y., Tan, H., & Ren, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495900 · Cited by 86
Sun, L., Li, J., Yan, W., Yao, Z., Wang, R., Zhou, X., Wu, H., Zhang, G., Shi, T., & Chen, W. (2021) · Cancer Science · doi:10.1111/cas.14896 · Cited by 85
p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis
Wang, F., Qi, X.-M., Wertz, R., Mortensen, M., Hagen, C. E., Evans, J., Sheinin, Y. M., James, M. A., Liu, P., Tsai, S., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3281 · Cited by 84
High glucose: an emerging association between diabetes mellitus and cancer progression
Supabphol, S., Seubwai, W., Wongkham, S., & Saengboonmee, C. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02096-w · Cited by 84
Seo, M., Kim, J., Neau, D. B., Sehgal, I., & Lee, Y. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024179 · Cited by 83
Cited by
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
Metadata
- Authors
- Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2024-03
- Volume
- 14
- Issue
- 3
- Pages
- 953-1008
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W4389833823
- Cited by
- 261
- References
- 562
- FWCI
- 25.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.